Subtle Medical vs Ultromics EchoGo
Subtle Medical sells scanner-side image enhancement and Ultromics sells an echo reading aid, so the two answer different questions. Subtle's SubtleHD runs on MR, PET and CT, and the vendor says it makes MRI sequences up to 80% faster and PET scans up to 75% faster. Its buyer is an imaging department with scanner time to recover. Ultromics' buyer is a cardiology group with an echo lab, because EchoGo Heart Failure flags findings suggestive of HFpEF from a single apical four-chamber view in adults over 25 with an ejection fraction of 50% or higher. Neither homepage shows a price. On clearances, openFDA lists 11 510(k) decisions for Subtle Medical, the latest K254120 for SubtleHD-CT on May 15, 2026, and 6 for Ultromics, the latest K240860 for EchoGo Amyloidosis on November 15, 2024. A department buying faster MR protocols is not buying echo interpretation, so the clinical problem decides.
Radiology · Reviewed November 2, 2026
Subtle Medical
by Subtle Medical
Vendor-neutral deep-learning software that improves MR, PET and CT image quality on faster or lower-dose protocols.
Ultromics EchoGo
by Ultromics
FDA-cleared AI on echocardiograms that flags heart failure with preserved ejection fraction and screens for cardiac amyloidosis.
When to pick each one
Subtle Medical
- Vendor-neutral MR, PET and CT image enhancement
- Eleven openFDA 510(k) decisions, latest SubtleHD-CT in May 2026
- Enterprise tier with no public price
Ultromics EchoGo
- Flags HFpEF from one apical four-chamber echo view
- Cleared amyloidosis screening aid, K240860
- ISO 13485:2016 and ISO/IEC 27001:2022 listed in its Trust Center
Score
Each row shows points earned of points available under the published rubric.
Subtle Medical
37of 100
Ultromics EchoGo
42of 100
| Dimension | Subtle Medical | Ultromics EchoGo | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 6 / 10 | -6 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 7.3 / 18.2 | 0 / 18.2 | +7.3 |
| RCT / meta-analysis / systematic review | 0 / 7.8 | 0 / 7.8 | 0 |
| Funding & adoption signal | 3 / 12 | 8.4 / 12 | -5.4 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Subtle Medical
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Billing period, trial and refund not stated. |
Ultromics EchoGo
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Subtle Medical
FDA decisions
K254120 (opens in new tab)510(k)2026-05-15
SubtleHD-CT 1.x
K254013 (opens in new tab)510(k)2026-05-14
SubtleHD-PET 1.x
K243250 (opens in new tab)510(k)2025-02-12
SubtleHD 1.x
K240290 (opens in new tab)510(k)2024-08-21
AiMIFY 1.x
K241329 (opens in new tab)510(k)2024-07-11
SubtleSYNTH 1.x
Show 6 more
K233699 (opens in new tab)510(k)2024-04-29
SubtleREFORMAT 1.x
K223623 (opens in new tab)510(k)2023-05-11
SubtleMR 2.3.x
K211964 (opens in new tab)510(k)2021-09-28
SubtlePET
K203182 (opens in new tab)510(k)2021-02-26
SubtleMR
K191688 (opens in new tab)510(k)2019-09-16
SubtleMR
K182336 (opens in new tab)510(k)2018-11-30
SubtlePET
Peer-reviewed
1 PubMed record names Subtle Medical.
Ultromics EchoGo
FDA decisions
K240860 (opens in new tab)510(k)2024-11-15
EchoGo Amyloidosis (1.0)
K240013 (opens in new tab)510(k)2024-09-23
EchoGo Heart Failure (2.0)
K222463 (opens in new tab)510(k)2022-11-23
EchoGo Heart Failure 1.0
K213275 (opens in new tab)510(k)2021-12-20
EchoGo Core (2.0)
K201555 (opens in new tab)510(k)2020-12-18
EchoGo Pro v1.0.2
Show 1 more
K191171 (opens in new tab)510(k)2019-11-13
EchoGo Core
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Subtle Medical | Ultromics EchoGo |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | n/a |
| HQ | n/a | GB |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.